GMED Globus Medical, Inc.
USHealthcareAs of 2026-07-10 16:00
Why GMED matters now
Globus Medical, Inc. (GMED) is a US stock in Healthcare. The latest InvestLog snapshot shows $78.11 with +1.92% on the session and $10.53B in market capitalization; recent performance reads 1-month -0.88% and YTD -9.25%.
The latest financial table shown here is Q1 2026, with revenue of $759.9M, net income of $124.3M, and EPS of $0.90. Investors can compare that operating picture with valuation signals such as P/E 22.74 and FCF yield 5.6%.
The latest indexable market news headline is "Here's Why Globus Medical (GMED) is a Strong Momentum Stock" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $111.00; recent insider activity includes Davidar David D filing M-Exempt. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
22.74
PEG
0.05
P/B
2.27
P/S
3.45
EV/EBITDA
11.64
DCF Value
$39.71
FCF Yield
5.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.9%
Operating Margin
17.6%
Net Margin
18.9%
ROE
13.0%
ROA
10.8%
ROIC
9.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $759.9M | $124.3M | $0.90 |
| Q4 2025 | $826.4M | $140.6M | $1.01 |
| FY 2025 | $2.94B | $537.9M | $3.92 |
| Q3 2025 | $769.0M | $119.0M | $0.88 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$109.50
Target (Median)
$111.00
Target Range
$100.00 - $117.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.95
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.